Skip to main content

Diagnostic options Β· UAE

Molecular Diagnostics tests in Dubai & UAE

Compare available Molecular Diagnostics tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

781

Listed price range

550.00–150,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Molecular Diagnostics test prices

Showing 616–630 of 781 matching tests.

Molecular Diagnostics diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-679
PML/RARA Quantitative Test

This test quantifies the PML/RARA fusion gene transcript, a key marker for Acute Promyelocytic Leukemia (APL).

Bone marrow aspirate or peripheral whole blood 24 hours (phone) / 36 hours (email) – starting 3rd working day 1,400.00 AED
View
View test specifications and preparation
What it measures
["PML/RARA fusion gene transcript", "Minimal Residual Disease (MRD)"]
Parameters
[]
Preparation
["No special preparation or fasting required", "Sign consent form", "Provide complete clinical history", "Avoid vigorous exercise for two hours before collection"]
Indications
["Diagnosis of Acute Promyelocytic Leukemia (APL)", "Risk stratification in APL", "Minimal Residual Disease (MRD) monitoring in APL"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 33587-2 ICD-10: C92.4
Clinical summary
This test quantifies the PML/RARA fusion gene transcript, a key marker for Acute Promyelocytic Leukemia (APL).
TEST-2914
PML/RARA t(15;17)(q22;q12) Gene Rearrangement Qualitative PCR Test

This test detects the presence or absence of the PML-RARA fusion transcript, a genetic marker specific for acute promyelocytic leukemia (APL).

Whole blood (EDTA) – 3 mL minimum Next Tuesday, Thursday, or Saturday after sample collection (by 6:00 PM) 1,200.00 AED
View
View test specifications and preparation
What it measures
["PML-RARA fusion transcript", "Gene rearrangement t(15;17)(q22;q12)"]
Parameters
[]
Preparation
["No fasting required", "Stay well hydrated", "Have Emirates ID and Genomics Clinical Information Requisition Form (Form 20) ready"]
Indications
["Suspected Acute Promyelocytic Leukemia (APL)", "Monitoring for Minimal Residual Disease (MRD) in APL"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 43399-9 ICD-10: C92.50, Z15.09, C92.52
Clinical summary
This test detects the presence or absence of the PML-RARA fusion transcript, a genetic marker specific for acute promyelocytic leukemia (APL).
TEST-4052
PMP22 Gene CMT1A Genetic Test

This test detects copy number variations (duplications or deletions) within the PMP22 gene.

Peripheral whole blood 3 to 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["PMP22 gene copy number variants (duplications, deletions)"]
Parameters
[]
Preparation
[]
Indications
["Clinical suspicion of Charcot-Marie-Tooth disease type 1A (CMT1A)", "Individuals with symptoms of hereditary peripheral neuropathy", "Genetic counselling for families with a history of CMT1A"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81252-9 ICD-10: G60.0
Clinical summary
This test detects copy number variations (duplications or deletions) within the PMP22 gene.
TEST-2099
PMS2 Gene (Lynch Syndrome) Genetic Test

This test evaluates the PMS2 gene for mutations associated with Lynch syndrome Type 4, a hereditary condition increasing cancer risk.

Whole blood (EDTA), extracted genomic DNA, or FTA card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["PMS2 gene sequence", "Copy Number Variations (CNVs) in PMS2 gene"]
Parameters
[]
Preparation
["No specific fasting required.", "Inform the team about recent blood transfusions (within 2 weeks).", "Consult oncologist regarding optimal timing if undergoing active chemotherapy.", "Discuss alternative sample types if history of allogeneic bone marrow transplant."]
Indications
["Individuals with a strong family history of colorectal or endometrial cancer meeting Amsterdam or revised Bethesda criteria.", "Individuals with a known PMS2 variant in the family."]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: Z15.09, Z80.3
Clinical summary
This test evaluates the PMS2 gene for mutations associated with Lynch syndrome Type 4, a hereditary condition increasing cancer risk.
TEST-4719
POMK Gene Limb‑Girdle Muscular Dystrophy Type 12C Genetic Test

This diagnostic test evaluates the POMK gene for pathogenic variants associated with limb-girdle muscular dystrophy type 12C (LGMDR12).

Peripheral whole blood (EDTA tube) or buccal swab (DNA FTA card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the POMK gene", "Single-nucleotide variants (SNVs)", "Small insertions/deletions (indels)", "Copy-number variants (CNVs)"]
Parameters
[]
Preparation
["No specific fasting required.", "Inform the phlebotomist of any medications you are taking."]
Indications
["Clinical suspicion of limb-girdle muscular dystrophy type 12C", "Family history of LGMDR12", "Need for definitive genetic diagnosis for treatment planning and genetic counseling"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82128-5 ICD-10: G71.0, Z13.7, Z82.79
Clinical summary
This diagnostic test evaluates the POMK gene for pathogenic variants associated with limb-girdle muscular dystrophy type 12C (LGMDR12).
TEST-399
Pork Meat Adulteration Testing Test

This test detects the presence or absence of porcine DNA in food samples.

Food Product Sample (Raw, Cooked, or Processed Meat/Food Items) 5–7 business days 750.00 AED
View
View test specifications and preparation
What it measures
["Porcine mitochondrial cytochrome b DNA fragments", "Porcine protein biomarkers"]
Parameters
[{"name": "Porcine DNA Detection", "reference_range": "Negative / Positive"}, {"name": "Pork Content (w/w)", "reference_range": "Detection Limit: 0.01% w/w"}]
Preparation
["Ensure a minimum of 10 grams of the suspected food product is available.", "Place the sample in a clean, sealable plastic bag or airtight container.", "Store in a refrigerator if not submitting immediately.", "Avoid cross-contamination."]
Indications
["Halal certification verification", "Regulatory compliance testing", "Consumer safety assurance", "Verification of food product integrity"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 83088-6 ICD-10: Z02.89, Z71.0, Z91.89
Clinical summary
This test detects the presence or absence of porcine DNA in food samples.
TEST-2015
POT1 Gene Melanoma Susceptibility Test (Familial Type 10)

This test evaluates the POT1 gene for germline mutations associated with an increased risk of hereditary cutaneous malignant melanoma.

Whole Blood (EDTA) or Dried Blood Spots (FTA Card) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Germline mutations in the POT1 gene", "Pathogenic variants associated with melanoma risk"]
Parameters
[]
Preparation
["No special fasting required", "Genetic counselling session required before sample collection"]
Indications
["Individuals with a strong family history of melanoma", "Patients with multiple primary melanomas", "Individuals diagnosed with melanoma before age 40"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93931-7 ICD-10: Z15.09
Clinical summary
This test evaluates the POT1 gene for germline mutations associated with an increased risk of hereditary cutaneous malignant melanoma.
TEST-6190
PPP1R17 Gene Hypercholesterolemia Susceptibility Test (NGS)

This test evaluates genetic variants in the PPP1R17 gene associated with increased susceptibility to hypercholesterolemia.

Peripheral whole blood (EDTA) 3 – 4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Genetic variants in the PPP1R17 gene"]
Parameters
[]
Preparation
["Detailed clinical history required", "Mandatory genetic counselling session", "Fasting is not required"]
Indications
["Family history of hypercholesterolemia", "Early onset cardiovascular disease", "Screening for genetic predisposition to high cholesterol"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82939-0 ICD-10: E78.0, Z13.89
Clinical summary
This test evaluates genetic variants in the PPP1R17 gene associated with increased susceptibility to hypercholesterolemia.
TEST-4340
PRDM16 Gene Cardiomyopathy, Dilated Type 1LL Genetic Test

This genetic test identifies pathogenic variants in the PRDM16 gene associated with dilated cardiomyopathy type 1LL.

Whole Blood (EDTA), Dried Blood Spot (FTA Card), or Extracted DNA 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["PRDM16 gene sequence", "Copy number variations in PRDM16"]
Parameters
[]
Preparation
["No fasting required", "Pre-test genetic counselling session mandatory"]
Indications
["Diagnosis confirmation in symptomatic patients", "Genetic risk assessment in asymptomatic family members"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 103388-3 ICD-10: I42.0, Z13.6, Z15.89
Clinical summary
This genetic test identifies pathogenic variants in the PRDM16 gene associated with dilated cardiomyopathy type 1LL.
TEST-1210
Preimplantation Genetic Diagnosis (PGD) for Single‑Gene Disorders Test

This test screens embryos for specific single-gene disorders using Sanger sequencing on trophectoderm cells, including a maternal contamination check.

Trophectoderm Biopsy (Embryo Cells) 15-20 days from biopsy receipt 5,000.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in single-gene disorders", "Maternal DNA contamination"]
Parameters
[]
Preparation
[]
Indications
["Couples undergoing IVF with known single-gene disorder carrier status"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 90577-7 ICD-10: Z31.49
Clinical summary
This test screens embryos for specific single-gene disorders using Sanger sequencing on trophectoderm cells, including a maternal contamination check.
TEST-473
Prenatal Paternity Test (Amniotic Fluid)

This test determines biological paternity during pregnancy by analyzing fetal DNA extracted from amniotic fluid.

Amniotic Fluid 7–10 business days 2,800.00 AED
View
View test specifications and preparation
What it measures
["Fetal DNA profile", "Comparison with mother and alleged father DNA"]
Parameters
[]
Preparation
["No special fasting or medication changes unless directed by your obstetrician.", "Bring valid Emirates ID or passport.", "Complete chain-of-custody consent forms at the hospital."]
Indications
["Need for legal paternity determination during pregnancy", "Personal certainty regarding paternity during pregnancy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21774-3 ICD-10: Z31.82
Clinical summary
This test determines biological paternity during pregnancy by analyzing fetal DNA extracted from amniotic fluid.
TEST-1961
PRKAR1A Gene Myxoma, Intracardiac Genetic Test

This test detects pathogenic variants in the PRKAR1A gene associated with Carney complex and intracardiac myxoma.

Whole blood, extracted DNA, or dried blood spot (FTA card) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the PRKAR1A gene", "Single-nucleotide variants", "Small insertions/deletions"]
Parameters
[]
Preparation
[]
Indications
["Clinical suspicion of Carney complex", "Intracardiac myxoma", "Family history of Carney complex or myxoma"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: D15.1
Clinical summary
This test detects pathogenic variants in the PRKAR1A gene associated with Carney complex and intracardiac myxoma.
TEST-4011
PROC Gene Protein C Deficiency (AD) Genetic Test

This genetic test identifies pathogenic variants in the PROC gene associated with autosomal dominant Protein C deficiency.

Whole blood (peripheral) 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["PROC gene sequence", "Pathogenic variants (point mutations, indels, CNVs)"]
Parameters
[]
Preparation
["No fasting required", "Inform doctor about all medications"]
Indications
["Suspected hereditary thrombophilia", "Family history of Protein C deficiency", "Guidance for thromboprophylaxis", "Family screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48769-0 ICD-10: D68.59, Z15.89, Z13.79
Clinical summary
This genetic test identifies pathogenic variants in the PROC gene associated with autosomal dominant Protein C deficiency.
TEST-2970
Prothrombin Gene Mutation Analysis (G20210A) Test

This test identifies the presence or absence of the G20210A mutation in the prothrombin gene (F2), a common genetic risk factor for venous thromboembolism.

Whole Blood – Lavender-Top EDTA Tube (3 mL) 72 Hours (Monday–Thursday Collection) 800.00 AED
View
View test specifications and preparation
What it measures
["Presence of G20210A mutation in the F2 gene", "Genetic predisposition to thrombophilia"]
Parameters
[{"name": "G20210A Mutation Status", "reference_range": "Negative (Wild-type), Heterozygous (Positive), Homozygous (Positive)"}]
Preparation
["No fasting required", "Routine medication (except as discussed with your doctor) does not interfere"]
Indications
["Assessment of inherited thrombophilia risk", "Evaluation of patients with personal or family history of VTE", "Work-up for unprovoked VTE, especially in younger individuals", "Investigation of recurrent thrombosis", "Assessment in pregnancy-related thrombosis cases"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81618-5 ICD-10: D68.52, D68.69, Z15.09
Clinical summary
This test identifies the presence or absence of the G20210A mutation in the prothrombin gene (F2), a common genetic risk factor for venous thromboembolism.
TEST-4070
PRPS1 Gene CMTX5 Genetic Test

This test identifies pathogenic variants within the PRPS1 gene associated with X-linked Charcot-Marie-Tooth Disease type 5 (CMTX5). It utilizes Next Generation Sequencing (NGS) to...

Peripheral Whole Blood (EDTA), Extracted Genomic DNA, or Dried Blood Spot (FTA Card) 3 to 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the PRPS1 gene", "Single nucleotide variants", "Small indels"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any anticoagulant therapy"]
Indications
["Suspected X-linked Charcot-Marie-Tooth Disease type 5 (CMTX5)", "Family history of CMTX5", "Complex neurological disorders requiring genetic confirmation"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 59001-0 ICD-10: G60.0
Clinical summary
This test identifies pathogenic variants within the PRPS1 gene associated with X-linked Charcot-Marie-Tooth Disease type 5 (CMTX5). It utilizes Next Generation Sequencing (NGS) to analyze the entire coding region and splice sites.

Category overview

Molecular Diagnostics: overview

When complex health questions arise, evaluating your health at the cellular level provides the definitive clarity necessary for proactive care. At DNA Labs UAE, our Molecular Diagnostics services harness the power of advanced nucleic acid amplification and real-time PCR technologies to detect diseases with unparalleled sensitivity. From identifying viral loads to pinpointing genetic markers, our specialized molecular testing in the UAE gives your healthcare provider the precise data needed to customize your medical strategy. Trust in one of the leading diagnostic labs in Dubai and the UAE to process your samples with rigorous confidentiality and exceptionally fast, accurate turnaround times. Step forward with absolute confidence. View our molecular diagnostics profiles below, request a seamless home sample collection, or contact our specialized team to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area